IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $212,000 | -15.9% | 2,488 | -81.0% | 0.12% | +24.7% |
Q1 2019 | $252,000 | +49.1% | 13,097 | +10.5% | 0.09% | -54.6% |
Q4 2018 | $169,000 | -34.7% | 11,855 | -4.5% | 0.20% | -53.2% |
Q3 2018 | $259,000 | +14.6% | 12,410 | -19.8% | 0.44% | +386.7% |
Q1 2018 | $226,000 | – | 15,474 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |